Reset Map15 Results
7850 Brier Creek Pkwy, Suite 310 Raleigh, North Carolina, 27617 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
325 W Germantown Pike, Suite 200 East Norriton, Pennsylvania, 19403 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
1000 Sandhill Road Reno, NV, 89521 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
50 Mill St. Arlington, Mass, 02476 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
1733 Creekside Dr Folsom, CA, 95630 3911 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
1743 Creekside Dr, Suite 200 Folsom, CA, 95630 3911 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
1230 Soldiers Field Dr Boston, MA, 02135 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
325 W Germantown Pike Norristown, PA, 19403 4207 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
9707 Medical Center Drive, Suite 230 | Rockville, MD 20850 Rockville, MD, 20850 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
2001 Junipero Serra Blvd Suite 620 Daly City, CA, 94010 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
7850 Brier Creek Pkwy, Suite 310 Raleigh, NC, 27617 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
325 W Germantown Pike, Suite 200 East Norriton, PA, 19403 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
1743 Creekside Drive Folsom, CA, 95630 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
4520 Executive Drive San Diego, CA, 92121 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
1230 Soldiers Field Rd Boston, MA, 02135 United StatesFor nearly two decades, CGT Global has transformed the biotechnology landscape, advancing research, drug discovery, translational science, clinical trials, and the development of innovative therapies in immunology and cell and gene therapy. As the leading biospecimen provider, we offer human bone marrow, cord blood, peripheral blood (Leukopaks®, Mobilized Leukopaks®, and whole blood), maternal blood, plasma, serum, disease-state products, and primary cells. Our expertise allows us to provide individualized attention to researchers’ needs, accelerating discoveries and supporting the commercialization of new treatments. With multiple Collection Centers strategically located across the USA, biospecimens are collected from IRB-consented donors and either shipped directly to our customers or quickly processed at our on-site cell manufacturing laboratories into high-quality primary cell products. These facilities enable fully customizable orders, from donor recruitment to the processing of specific cell types. Cell products are available regionally via direct shipment or globally through our network of distributors, ensuring fast and reliable delivery. Our cGMP-compliant cell manufacturing facility provides high-quality human blood and cells manufactured under strict standards, facilitating a seamless transition from basic research to clinical studies and easing the path through the FDA approval process. Through partnerships with leading pharmaceutical companies, healthcare providers, and clinical research organizations, we drive therapeutic breakthroughs and expand patient access to innovative treatments. For more information about our donor recruitment, apheresis collections, and cell processing, Clinical Research Organization (CRO) support or analysis, please visit www.cgt.global
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.